![]() Professor Elina Hypponen of the University of South Australia was awarded $1.3million by the Medical Research Future Fund. Predicting and preventing ovarian cancer: a machine learning approach If successful, this project has the potential to detect ovarian cancer at its most curable stage. Using the samples from the largest screening study to date, the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) the team will evaluate the performance of the new test against the CA125 biomarker and the Risk of Ovarian Cancer Algorithm evaluation method that was used in the UKCTOCS trial. Associate Professor Salomon and his team will now expand upon the initial promising results to determine if the test could be used for screening of the general population. Considering the support of the OCRF in the initial stages of this research, Associate Professor Salomon has named the central algorithm of his new project ‘OCRF-7’. ![]() The biomarkers identified were also associated with the extracellular signalling pathway, used by cancer cells to promote metastatic activity, which is important for understanding the way ovarian cancer spreads. This test is focused on identifying High Grade Serous Ovarian Cancer which is responsible for most ovarian cancer mortality. Implementing a rapid blood test for the early detection of ovarian cancerĪssociate Professor Carlos Salomon from the University of Queensland was awarded over $2million by the Medical Research Future Fund.Īssociate Professor Salomon and his team previously undertook a discovery project that was funded by the OCRF, which identified a new type of test that showed promising results for identifying ovarian cancer in its early stages, including asymptomatic stages. ![]() Project: Identifying new treatment options for the rare and aggressive ovarian carcinosarcoma A Grants-in-Aid project has been jointly funded to a maximum of $100,000 per year for up to three years, to support a specific ovarian cancer research project. This model aims to access established and rigorous research assessment processes already in place to ensure the best research applications are supported – with the ultimate aim of improving outcomes for people affected by low survival cancers. Cancer Council Victoria has sought ways to increase investment for research into low survival cancers, such as ovarian cancer, and has agreed to co-fund a Grants-in-Aid award with the OCRF. ![]() As an independent not-for-profit organisation, they play a leading role in reducing the impact of all cancers on all people. Project: Development of a novel combination therapy to target triple-negative breast and high-grade serous ovarian cancersĬancer Council Victoria has developed an international reputation for innovative work in cancer research, prevention, and support. Ovarian and Breast Cancer Research Collaboration Initiative Grant Recipient Announced The total amount available for this funding opportunity is $1 million over three-to-five years, evenly split between the two organisations for one or two research projects. The NBCF and the OCRF have agreed to jointly fund high impact translational research that spans both ovarian and breast cancers to improve outcomes for women. These developments offer exciting opportunities to support collaborative cancer research projects that consider shared approaches to treating breast and ovarian cancer. Emerging evidence suggests that there is significant overlap in the mutation profile and endocrine-driven signalling pathways of patients with breast cancer and ovarian cancer. The National Breast Cancer Foundation (NBCF) is Australia’s leading national body funding research into breast cancer with the aim of stopping all deaths from breast cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |